title: Romiplostim mitigates dose-limiting thrombocytopenia of erucic acid for adrenomyeloneuropathy.
authors: Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles (UCLA), Los Angeles, CA, USA. dsshin@mednet.ucla.edu.|Department of Molecular, Cellular and Integrative Physiology, UCLA, Los Angeles, CA, USA. dsshin@mednet.ucla.edu.
authors: Daniel Sanghoon
authors: DS
authors: Shin
authors: Department of Neurology, University of California Los Angeles, Los Angeles, CA, USA.
authors: Susan
authors: S
authors: Perlman
authors: Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles (UCLA), Los Angeles, CA, USA.
authors: Michael H
authors: MH
authors: Rosove
mesh_terms: D000279:Administration, Cutaneous; D000326:Adrenoleukodystrophy / Q000188:drug therapy*; D000368:Aged; D004791:Enzyme Inhibitors / Q000009:adverse effects*; D004883:Erucic Acids / Q000009:adverse effects*; D006397:Hematinics / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D011961:Receptors, Fc / Q000008:administration & dosage*; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage*; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000517:prevention & control; D013926:Thrombopoietin / Q000008:administration & dosage*
chemical_list: D004791:Enzyme Inhibitors; D004883:Erucic Acids; D006397:Hematinics; D011961:Receptors, Fc; D011993:Recombinant Fusion Proteins; C049811:erucic acid; D013926:Thrombopoietin; C488777:romiplostim
keywords: adrenomyeloneuropathy; erucic acid; thrombocytopenia; thrombopoiesis